FT Global Pharma and Biotech Summit

Artificial intelligence is transforming the pharmaceutical industry, from speeding up drug discovery to improving patient outcomes. But to move beyond experiments and pilots, pharma companies need to embed AI into everyday operations.

Join Dr Angeli Möller, Group Chief Health Officer at Zühlke, alongside other industry experts, as they discuss AI in Pharma: From Trial and Error to Business as Usual.

2:00-2:40 PM | Main Stage

Dr Möller will kick off the discussion with her key takeaways from the World Health Summit in Berlin, where she will be speaking in October.

The panel will then explore:

• Opportunities and challenges in standardising AI across pharma functions

• Supporting employees in adopting AI as a mainstream tool

• Governance frameworks for compliant AI integration

• The future outlook on AI standardisation as capabilities evolve

With the industry facing growing pressure from regulation, system overload, and global risks, this discussion will focus on making AI practical, scalable, and impactful in real-world settings.

See the full event agenda here.